NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on multiple sclerosis and myasthenia gravis in early trial
Disease control Not yet recruitingThis early-stage study tests a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with severe autoimmune diseases like multiple sclerosis, neuromyelitis optica, and myasthenia gravis. Up to 1…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
Silent attacks in NMOSD: new study aims to predict disability before it strikes
Knowledge-focused Not yet recruitingThis study follows 50 adults with neuromyelitis optica spectrum disorder (NMOSD) who appear stable on standard treatment. Researchers will use blood tests and MRI scans to look for signs of hidden damage that could predict future relapses or disability. The goal is to better unde…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC